RORA and Parkinson disease: Complementary to our results with the RORA antagonist, we have shown that exogenous application of the RORα/γ agonist, SR1078, in our in vitro PD model consistently protects the N27 neurones against 6-OHDA induced degeneration, and subsequent investigations focused on the underlying mechanisms.